The availability of whole-genome association studies has redefined the genetic architecture of genetically complex disorders, and genotyping and resequencing will reveal new susceptibility genes for a wide range of common human diseases. The emphasis of the field is thus changing from focusing on the identification of susceptibility genes towards an understanding of mechanisms and potential applications.
Following the successful inaugural conference in Hinxton, Cambridge, UK in July 2007, this second meeting, organised by Nature Genetics and the Wellcome Trust, will take place from 6 to 9 September 2008, at The Broad Institute of MIT and Harvard, Cambridge, MA, USA aims to address the following topics, across a range of common diseases:
—The state of the art in gene-identification strategies
—The transition from knowledge of susceptibility genes to understanding of mechanisms
—Population genetics and genome evolution in common-disease genetics
—The utility of risk prediction based on genetic and other available tests
—Ethical, legal and social implications of personal genetic information.
Please see the conference website for further details of the organizers, speakers, abstract submission, accommodation and more.